Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid progress for its VK2735...
Vous n'êtes pas connecté
Maroc - ZACKS.COM - All Stories - 11/07/2024 13:02
United Therapeutics' (UTHR) late-stage study is evaluating Tyvaso inhalation solution in IPF patients living outside the United States and Canada.
Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid progress for its VK2735...
Viking Therapeutics completes enrollment in its phase III VANQUISH-1 obesity study, surpassing targets and marking rapid progress for its VK2735...
New international undergraduate (UG) and postgraduate (PG) enrolment has declined sharply in the United States and Canada this fall, according to a...
RAHWAY, N.J.--(BUSINESS WIRE) November 19, 2025 -- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced topline...
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Belize continues to benefit from rising remittance flows in 2025, according to the latest Inter-American Development Bank (IDB) technical report on...
Belize continues to benefit from rising remittance flows in 2025, according to the latest Inter-American Development Bank (IDB) technical report on...
TUESDAY, Dec. 2, 2025 — A small but closely watched study is giving researchers new optimism in the search for long-term HIV control, and...
TUESDAY, Dec. 2, 2025 — A small but closely watched study is giving researchers new optimism in the search for long-term HIV control, and...